House David Duane 4
4 · Armata Pharmaceuticals, Inc. · Filed Oct 3, 2024
Insider Transaction Report
Form 4
House David Duane
SVP, Finance, and PFO
Transactions
- Award
Stock Options (Right to Buy)
2024-10-02+75,000→ 75,000 totalExercise: $2.32Exp: 2034-10-02→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The Options shall vest and become exercisable 25% on August 16th of each of 2025, 2026, 2027, and 2028, in each case subject to continuous service through the applicable vesting date.